Thursday, 16 October 2014

AbbVie board abandons $55 billion Shire merger

The board of American drug company AbbVie is walking away from its merger with U.K. rival Shire, making the $55 billion deal the first casualty of the Obama Administration's crackdown on companies seeking to lower their tax bills.

No comments:

Post a Comment